Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Lung Cancer Case Registry and Tissue Resource

This study has been completed.
Information provided by (Responsible Party):
University of New Mexico Identifier:
First received: November 4, 2005
Last updated: June 9, 2016
Last verified: June 2016
Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the Cancer Research and Treatment Center (CRTC) and New Mexico Veterans Health Care System (NMVHCS).

Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Lung Cancer Case Registry and Tissue Resource

Resource links provided by NLM:

Further study details as provided by University of New Mexico:

Primary Outcome Measures:
  • DNA Change [ Time Frame: one year ]

Biospecimen Retention:   Samples With DNA
Blood samples, and sputum (phlegm) samples.

Enrollment: 750
Study Start Date: March 2004
Study Completion Date: June 2016
Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Detailed Description:
Lung cancer is the most common cause of cancer death in the US in both men and women. This research study will enroll lung cancer patients into a registry to study changes in DNA (or genetic material) that may be associated with development of lung cancer or other lung diseases such as chronic obstructive pulmonary disease (COPD). We will also study the role of eating habits on lung cancer diagnosis and treatment, as well as the effects of the disease and treatment on quality of patient's lives.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients (male or female) with Lung cancer.

Inclusion Criteria:

  • Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the CRTC and NMVHCS. Recruiting will primarily be performed through the Multidisciplinary Chest Clinics held weekly at each hospital. These clinics are staffed by the Principal Investigator (PI) and Reza Mehran, MD, a thoracic surgeon at both hospitals and a co-investigator on this submission. Approximately 90% of all lung cancer cases diagnosed at the NMVHCS, and a somewhat smaller proportion of cases treated in the Cancer Center, are seen in these clinics. Additional cases will be identified through review of new patient visits to each hospital with a diagnosis of lung cancer; Drs. Crowell and Mehran also maintain weekly contact with pathology and oncology services at both facilities, which will facilitate case identification at NMVHCS and University Hospital. Finally, patient contact records will be correlated with tumor registry records at both hospitals, which will identify any cases not captured through the above mechanisms. Although these cases may be identified several weeks after initial diagnosis, all attempts will still be made to contact the patient and family for enrollment into the registry. Most Spanish-speaking patients served by the CRTC and the NMVHCS are bilingual, and a language barrier has not been a problem in other similar studies conducted by the PI. However, Spanish-speaking personnel are available to obtain consent and answer any questions if necessary.

Exclusion Criteria:

  • Patients will be excluded if they cannot provide written informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00250848

United States, New Mexico
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States, 87106
New Mexico Veterans Administration Health Care System
Albuquerque, New Mexico, United States, 87108
Sponsors and Collaborators
University of New Mexico
Principal Investigator: Richard Crowell, MD University of New Mexico
  More Information

Responsible Party: University of New Mexico Identifier: NCT00250848     History of Changes
Other Study ID Numbers: 2903C
Study First Received: November 4, 2005
Last Updated: June 9, 2016

Keywords provided by University of New Mexico:
Lung Diseases

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases processed this record on May 24, 2017